DecompDiff: Diffusion Models with Decomposed Priors for Structure-Based Drug Design
Designing 3D ligands within a target binding site is a fundamental task in drug discovery. Existing structured-based drug design methods treat all ligand atoms equally, which ignores different roles of atoms in the ligand for drug design and can be less efficient for exploring the large drug-like molecule space. In this paper, inspired by the convention in pharmaceutical practice, we decompose the ligand molecule into two parts, namely arms and scaffold, and propose a new diffusion model, DecompDiff, with decomposed priors over arms and scaffold. In order to facilitate the decomposed generation and improve the properties of the generated molecules, we incorporate both bond diffusion in the model and additional validity guidance in the sampling phase. Extensive experiments on CrossDocked2020 show that our approach achieves state-of-the-art performance in generating high-affinity molecules while maintaining proper molecular properties and conformational stability, with up to -8.39 Avg. Vina Dock score and 24.5 Success Rate. The code is provided at https://github.com/bytedance/DecompDiff
Code (2)
Tasks
AvgDrug DesignDrug DiscoveryMethods 이 논문이 사용한 방법론
Similar Papers 제목 키워드 기반
BoKDiff: Best-of-K Diffusion Alignment for Target-Specific 3D Molecule Generation
Structure-based drug design (SBDD) leverages the 3D structure of biomolecular targets to guide the creation of new therapeutic agents. Recent advances in generative models, including diffusion models and geometric deep l…
3D Molecule GenerationDrug DesignDrug DiscoveryDecompOpt: Controllable and Decomposed Diffusion Models for Structure-based Molecular Optimization
Recently, 3D generative models have shown promising performances in structure-based drug design by learning to generate ligands given target binding sites. However, only modeling the target-ligand distribution can hardly…
Drug DesignDrug DiscoveryDecomposed Direct Preference Optimization for Structure-Based Drug Design
Diffusion models have achieved promising results for Structure-Based Drug Design (SBDD). Nevertheless, high-quality protein subpocket and ligand data are relatively scarce, which hinders the models' generation capabiliti…
Drug DesignReprogramming Pretrained Target-Specific Diffusion Models for Dual-Target Drug Design
Dual-target therapeutic strategies have become a compelling approach and attracted significant attention due to various benefits, such as their potential in overcoming drug resistance in cancer therapy. Considering the t…
Drug DesignReimagining Target-Aware Molecular Generation through Retrieval-Enhanced Aligned Diffusion
Breakthroughs in high-accuracy protein structure prediction, such as AlphaFold, have established receptor-based molecule design as a critical driver for rapid early-phase drug discovery. However, most approaches still st…
Drug DesignDrug DiscoveryProtein Structure PredictionRetrieval+2